LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
21 1월 2025 - 11:00PM
Business Wire
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology
company, will host a conference call to discuss its fourth-quarter
and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m.
London time (8 a.m. Eastern Time). The Company will release its
fourth-quarter and full-year 2024 results prior to the call.
The audiocast will be accessible at www.livanova.com/events.
Listeners should log on approximately 10 minutes in advance to
ensure proper setup to receive the audiocast. To listen to the
conference call by telephone, dial +1 833 470 1428 (if dialing from
within the U.S.) or +1 929 526 1599 (if dialing from outside the
U.S.). The conference call access code is 982570. A replay will be
available on the LivaNova website for 90 days following the
call.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
provide hope for patients and their families through medical
technologies, delivering life-changing solutions in select
neurological and cardiac conditions. Headquartered in London,
LivaNova employs approximately 2,900 employees and has a presence
in more than 100 countries for the benefit of patients, healthcare
professionals, and healthcare systems worldwide. For more
information, please visit www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements”
concerning the Company’s goals, beliefs, expectations, strategies,
objectives, plans, underlying assumptions, and other statements
that are not necessarily based on historical facts. These
statements include, but are not limited to, statements regarding
the next Company conference call. Actual events may differ
materially from those indicated in our forward-looking statements
as a result of various factors, including those factors set forth
in Item 1A of the Company’s most recent Annual Report on Form 10-K,
as supplemented by any risk factors contained in Quarterly Reports
on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes
no obligation to update the information contained in this press
release to reflect subsequently occurring events or
circumstances.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250121495059/en/
LivaNova Investor Relations and Media Contacts +1
281-895-2382 Briana Gotlin VP, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke VP, Corporate Communications
Corporate.Communications@livanova.com
LivaNova (NASDAQ:LIVN)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
LivaNova (NASDAQ:LIVN)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
